Fig. 6From: TRPV6 plays a new role in predicting survival of patients with esophageal squamous cell carcinomaTwo cohorts both showed that TRPV6 played a contradicting role in predicting survival of male and female patients. Downregulation of TRPV6 was associated with a poor 3-year disease specific survival in patients with male in mRNA (a) and protein cohort (c). Downregulation of TRPV6 was significantly associated with favorable 3-year disease specific survival in patients with female in mRNA (b) and protein cohort (d)Back to article page